(Q39563429)

English

Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR-39).

scientific article published on 6 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR-39) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

3',4',5-trihydroxy-3,6,7-trimethoxyflavone

2 references

ChEBI release 2020-05-28

object named as

Vitex negundo

1 reference

based on heuristic

inferred from title

Vitex rotundifolia

1 reference

1 reference

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

8

object named as

Hiroyasu Esumi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Thein Zaw Linn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Feng Li

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Yasuhiro Tezuka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Aung Myint

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Akihiro Tomida

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Takao Yamori

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Shigetoshi Kadota

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

6 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Phytotherapy Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1770-1775

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluations

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Novel anticancer agents, kayeassamins A and B from the flower of Kayea assamica of Myanmar.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Novel anticancer agents, kayeassamins C-I from the flower of Kayea assamica of Myanmar

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Panduratins D-I, novel secondary metabolites from rhizomes of Boesenbergia pandurata

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FPTR.3441

21 January 2018

Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation

1 reference

https://opencitations.net/index/api/v1/references/10.1002/PTR.3441

10 April 2024

Three sesquiterpenes from Artemisia annua

1 reference

https://opencitations.net/index/api/v1/references/10.1002/PTR.3441

10 April 2024

Identifiers

10.1002/PTR.3441

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21469236%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39563429&oldid=2125469509"